Manish Kohli, MD
Medical Oncology · Salt Lake City, UTNPI 1407804040
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Advanced Accelerator Applications at 40.5% of the total.
Across 25 payments — averaging $525.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Accelerator Applications$5K
- Avyxa Pharma, LLC$4K
- Janssen Scientific Affairs, LLC$3K
- Sanofi$310
- Roche Diagnostics Corporation$136
- AstraZeneca$122
- plus $220 from 4 others
Across 1 payment — averaging $28,680 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$29K
What the payments were for
- Consulting fees$6,85152%
- Speaking & faculty fees$2,00015%
- Travel & lodging$3,11324%
- Food & beverage$1,1098%
- Education$761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Advanced Accelerator Applications | 4 | $5,330 |
| Avyxa Pharma, LLC | 7 | $4,316 |
| Janssen Scientific Affairs, LLC | 4 | $2,718 |
| Sanofi | 3 | $310 |
| Roche Diagnostics Corporation | 1 | $136 |
| AstraZeneca | 2 | $122 |
| Janssen Global Services, LLC | 1 | $74 |
| Tempus AI, Inc | 1 | $70 |
| Eisai Inc. | 1 | $51 |
| Merck | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$2,689
- NO PRODUCT DISCUSSED$287
- LYNPARZA$104
How this compares
$13,149 in reported general payments places this provider in the 65th percentile of 43 medical oncology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NubeqaDarolutamide | 43 | $563,854 |
| Abiraterone Acetate | 124 | $200,592 |
| Prednisone | 102 | $462 |
| Prochlorperazine Maleate | 11 | $158 |
| Ondansetron Hcl | 15 | $121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $2,718 | $200,592124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 43 medical oncology providers in Utah.
Other medical oncology in Salt Lake City
- Bradley HunterSalt Lake City$263K
- Robert HavardSalt Lake City$57K
- Wallace AkerleySalt Lake City$38K
- Ignacio Garrido-LagunaSalt Lake City$35K
- Mei WeiSalt Lake City$34K
- Xylina GreggSalt Lake City$31K
- Paul ShamiSalt Lake City$28K
- Nitin ChandramouliSalt Lake City$19K
- Kenneth GrossmannSalt Lake City$15K
- Peter HaleSalt Lake City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.